查看购物车
  • Traditional Chinese
  • English
2021-2031年欧洲临床试验市场报告：范围、细分、动态和竞争分析
市场调查报告书
商品编码
1871413

2021-2031年欧洲临床试验市场报告：范围、细分、动态和竞争分析

Europe Clinical Trials Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 136 Pages | 订单完成后即时交付

价格

欧洲临床试验市场预计将大幅成长，到 2031 年将达到约 200.5653 亿美元，高于 2023 年的 122.8673 亿美元，在此期间的年复合成长率(CAGR) 为 6.3%。

执行摘要和市场分析

欧洲临床试验市场分为多个区域，包括英国、法国、德国、义大利、西班牙、波兰、瑞士、瑞典、丹麦、比利时、荷兰以及欧洲其他地区。该市场预期成长的驱动力是旨在开发新药和推出创新产品的临床试验活动的增加。市场受益于健全的监管框架、完善的医疗保健基础设施以及对罕见疾病和慢性病的高度关注。监管机构和政府强调透明度和患者安全，而与合约研究组织 (CRO) 的合作则提高了营运效率。然而，冗长的审批流程和高昂的成本等挑战依然存在。

市场区隔分析

欧洲临床试验市场可以透过各种细分市场进行分析，包括研究设计、适应症和阶段类型。

1. 研究设计：市场分为干预性试验和扩大准入试验，其中干预性试验在 2023 年占据更大的市场份额。

2. 适应症：市场细分为多个治疗领域，包括自体免疫/发炎、疼痛管理、肿瘤、神经系统疾病、糖尿病、肥胖、代谢性疾病、心血管疾病等。 2023年，肿瘤领域占最大份额。

3. 阶段类型：市场分为 I 期、II 期和 III 期试验，其中 II 期试验在 2023 年占据市场份额的主导地位。

市场展望

分散式临床试验 (DCT) 因其允许参与者无需频繁前往医院即可参与试验而日益受到重视。这些试验利用数位技术进行远端资料收集、监测以及研究人员和参与者之间的沟通。结合居家和现场活动的混合模式也越来越受欢迎，这种模式能够提升患者体验并适应复杂的试验方案。最初，DCT 的推广应用面临许多挑战，例如对病患隐私、资料安全、监管问题以及复杂方案的担忧。然而，新冠疫情加速了分散式和混合模式的转变，因为传统的线下试验变得不再可行。麦肯锡的数据显示，约 70% 的潜在临床试验参与者无需前往试验中心，这凸显了分散式模式对于覆盖更广泛、更多样化的患者群体的重要性。

混合试验透过将分散式试验（DCT）要素融入研究设计，提供了更大的灵活性，吸引了更多申办方，并重塑了临床试验格局。美国食品药物管理局（FDA）预计2023年推出支持DCT方法的方案，进一步提升临床研究的公信力。对分散式试验和混合试验日益增长的重视，预计将在未来几年为临床试验市场创造丰厚的机会。

国家概况

欧洲临床试验市场涵盖英国、德国、法国、西班牙、义大利、波兰、瑞士、瑞典、丹麦、比利时、荷兰等主要国家。截至2023年，德国是该市场的领头羊，约占2021年全球临床试验总量的3.9%。德国拥有庞大的患者群体，对高品质医疗保健的需求旺盛。为促进学术临床研究，德国在联邦教育与研究部的资助下，设立了临床试验协调中心。德国的临床试验由联邦药品和医疗器材研究所或保罗·埃尔利希研究所监管，确保审批流程标准化、可靠且透明，审批时间相对较短。德国的主要合约研究组织（CRO），例如Sofpromed和CONET GmbH，提供涵盖各个阶段和各种类型研究的全面临床试验服务。

公司简介

临床试验市场的主要参与者包括QVIA Holdings Inc、Parexel International Corp、IXICO Plc、Charles River Laboratories International Inc、ICON Plc、药明康德股份有限公司、SGS SA、Syneos Health Inc、Thermo Fisher Scientific Inc、Laboratory Corp of America Holdings、CliniRx Research Private Limited、Caidyaal.这些公司正在推行扩张、产品创新以及併购等策略，以增强其市场份额并为客户提供创新解决方案。

目录

第一章：引言

第二章：执行概要

  • 关键见解

第三章：研究方法

  • 二手研究
  • 初步研究
    • 假设的提出：
    • 宏观经济因素分析：
    • 发展基础数字：
    • 数据三角测量：
    • 国家层面资料：

第四章：欧洲临床试验市场－主要市场动态

  • 市场驱动因素
    • 临床研究外包实务与试验数量大幅成长
    • 蓬勃发展的製药业，研发活动激增
  • 市场限制
    • 昂贵且耗时的过程
  • 市场机会
    • 采用分散式临床试验及混合式临床试验
  • 未来趋势
    • 人工智慧驱动的临床试验

第五章：临床试验市场—欧洲分析

  • 2021-2031年欧洲临床试验市场收入
  • 欧洲临床试验市场预测分析

第六章：欧洲临床试验市场分析－依研究设计划分

  • 干预性试验
  • 扩大使用试验

第七章：欧洲临床试验市场分析－依适应症划分

  • 自体免疫/炎症
  • 疼痛管理
  • 肿瘤学
  • 神经系统疾病
  • 糖尿病
  • 肥胖
  • 代谢紊乱
  • 心血管
  • 其他的

第八章：欧洲临床试验市场分析－以阶段类型划分

  • 第一阶段
  • 第二阶段
  • 第三阶段

第九章：欧洲临床试验市场—国家分析

  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 波兰
    • 瑞士
    • 瑞典
    • 丹麦
    • 比利时
    • 荷兰
    • 欧洲其他地区

第十章：竞争格局

  • 关键参与者热力图分析
  • 公司定位与集中度

第十一章：行业概况

  • 概述
  • 临床试验市场成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十二章：公司简介

  • QVIA Holdings Inc
  • Parexel International Corp
  • IXICO Plc
  • Charles River Laboratories International Inc
  • ICON Plc
  • WuXi AppTec Co Ltd
  • SGS SA
  • Syneos Health Inc
  • SIRO Clinpharm Pvt Ltd
  • Thermo Fisher Scientific Inc
  • Laboratory Corp of America Holdings
  • CliniRx Research Private Limited
  • Caidya
  • Oracle Corp
  • Medpace Holdings Inc

第十三章：附录

Product Code: BMIRE00028989

The clinical trials market in Europe is projected to grow significantly, reaching approximately USD 20,056.53 million by 2031, up from USD 12,286.73 million in 2023, reflecting a compound annual growth rate (CAGR) of 6.3% during this period.

Executive Summary and Market Analysis

The European clinical trials market is divided into several regions, including the UK, France, Germany, Italy, Spain, Poland, Switzerland, Sweden, Denmark, Belgium, the Netherlands, and other parts of Europe. The anticipated growth in this market is driven by an increase in clinical trial activities aimed at developing new drugs and launching innovative products. The market benefits from strong regulatory frameworks, a robust healthcare infrastructure, and a heightened focus on addressing rare and chronic diseases. Regulatory bodies and governments emphasize transparency and patient safety, while collaborations with contract research organizations (CROs) enhance operational efficiency. However, challenges such as lengthy approval processes and high costs persist.

Market Segmentation Analysis

The Europe clinical trials market can be analyzed through various segments, including study design, indications, and phase type.

1. Study Design: The market is categorized into interventional trials and expanded access trials, with interventional trials holding a larger market share in 2023.

2. Indications: The market is segmented into various therapeutic areas, including autoimmune/inflammation, pain management, oncology, neurological disorders, diabetes, obesity, metabolic disorders, cardiovascular diseases, and others. Oncology represented the largest share in 2023.

3. Phase Type: The market is divided into phase I, phase II, and phase III trials, with phase II trials dominating the market share in 2023.

Market Outlook

Decentralized clinical trials (DCTs) are gaining traction as they allow participants to engage in trials without frequent visits to hospital sites. These trials utilize digital technologies for remote data collection, monitoring, and communication between researchers and participants. A hybrid approach, which combines home-based and on-site activities, is also becoming popular, enhancing patient experience and accommodating complex protocols. Initially, the adoption of DCTs faced hurdles such as concerns over patient privacy, data security, regulatory issues, and intricate protocols. However, the COVID-19 pandemic accelerated the shift towards decentralized and hybrid methods, as traditional in-person trials became impractical. Data from McKinsey indicates that around 70% of potential clinical trial participants do not visit trial sites, highlighting the need for decentralization to access a broader and more diverse patient population.

Hybrid trials offer flexibility by integrating DCT elements into study designs, attracting more sponsors and reshaping the clinical trial landscape. The FDA is expected to introduce protocols supporting DCT methods in 2023, further enhancing the credibility of clinical research. The growing emphasis on decentralized and hybrid trials is anticipated to create lucrative opportunities for the clinical trials market in the coming years.

Country Insights

The European clinical trials market includes key countries such as the UK, Germany, France, Spain, Italy, Poland, Switzerland, Sweden, Denmark, Belgium, the Netherlands, and others. Germany is the leading country in this market as of 2023, accounting for approximately 3.9% of global clinical trials conducted in 2021. The country boasts a large patient population and a strong demand for high-quality healthcare. To promote academic clinical research, Germany has established coordinating centers for clinical trials under a funding initiative from the Federal Ministry of Education and Research. Clinical trials in Germany are regulated by the Federal Institute for Drugs and Medical Devices or the Paul-Ehrlich Institute, ensuring standardized, reliable, and transparent approval processes with relatively short timelines. Major CROs in Germany, such as Sofpromed and CONET GmbH, provide comprehensive clinical trial services across various phases and types of studies.

Company Profiles

Key players in the clinical trials market include QVIA Holdings Inc, Parexel International Corp, IXICO Plc, Charles River Laboratories International Inc, ICON Plc, WuXi AppTec Co Ltd, SGS SA, Syneos Health Inc, Thermo Fisher Scientific Inc, Laboratory Corp of America Holdings, CliniRx Research Private Limited, Caidya, Oracle Corp, Medpace Holdings Inc, and SIRO Clinpharm Pvt Ltd. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to clients.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Europe Clinical Trials Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Practice of Outsourcing Clinical Studies with Massive Rise in Number of Trials
    • 4.1.2 Flourishing Pharmaceutical Industry with Surge in R&D Activities
  • 4.2 Market Restraints
    • 4.2.1 Expensive and Time-Consuming Process
  • 4.3 Market Opportunities
    • 4.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
  • 4.4 Future Trends
    • 4.4.1 AI-Driven Clinical Trials

5. Clinical Trials Market - Europe Analysis

  • 5.1 Europe Clinical Trials Market Revenue (US$ Million), 2021-2031
  • 5.2 Europe Clinical Trials Market Forecast Analysis

6. Europe Clinical Trials Market Analysis - by Study Design

  • 6.1 Interventional Trials
    • 6.1.1 Overview
    • 6.1.2 Interventional Trials: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Expanded Access Trials
    • 6.2.1 Overview
    • 6.2.2 Expanded Access Trials: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Europe Clinical Trials Market Analysis - by Indications

  • 7.1 Autoimmune/Inflammation
    • 7.1.1 Overview
    • 7.1.2 Autoimmune/Inflammation: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Pain Management
    • 7.2.1 Overview
    • 7.2.2 Pain Management: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Oncology
    • 7.3.1 Overview
    • 7.3.2 Oncology: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Neurological Disorders
    • 7.4.1 Overview
    • 7.4.2 Neurological Disorders: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Diabetes
    • 7.5.1 Overview
    • 7.5.2 Diabetes: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Obesity
    • 7.6.1 Overview
    • 7.6.2 Obesity: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 Metabolic Disorders
    • 7.7.1 Overview
    • 7.7.2 Metabolic Disorders: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.8 Cardiovascular
    • 7.8.1 Overview
    • 7.8.2 Cardiovascular: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.9 Others
    • 7.9.1 Overview
    • 7.9.2 Others: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Clinical Trials Market Analysis - by Phase Type

  • 8.1 Phase I
    • 8.1.1 Overview
    • 8.1.2 Phase I: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Phase II
    • 8.2.1 Overview
    • 8.2.2 Phase II: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Phase III
    • 8.3.1 Overview
    • 8.3.2 Phase III: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Clinical Trials Market - Country Analysis

  • 9.1 Europe
    • 9.1.1 Europe Clinical Trials Market Overview
    • 9.1.2 Europe Clinical Trials Market - Revenue and Forecast Analysis - by Country
      • 9.1.2.1 Europe Clinical Trials Market - Revenue and Forecast Analysis - by Country
      • 9.1.2.2 United Kingdom: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.2.1 United Kingdom: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.2.2 United Kingdom: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.2.3 United Kingdom: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.3 Germany: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.3.1 Germany: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.3.2 Germany: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.3.3 Germany: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.4 France: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.4.1 France: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.4.2 France: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.4.3 France: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.5 Spain: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.5.1 Spain: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.5.2 Spain: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.5.3 Spain: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.6 Italy: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.6.1 Italy: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.6.2 Italy: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.6.3 Italy: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.7 Poland: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.7.1 Poland: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.7.2 Poland: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.7.3 Poland: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.8 Switzerland: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.8.1 Switzerland: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.8.2 Switzerland: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.8.3 Switzerland: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.9 Sweden: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.9.1 Sweden: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.9.2 Sweden: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.9.3 Sweden: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.10 Denmark: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.10.1 Denmark: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.10.2 Denmark: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.10.3 Denmark: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.11 Belgium: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.11.1 Belgium: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.11.2 Belgium: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.11.3 Belgium: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.12 Netherlands: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.12.1 Netherlands: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.12.2 Netherlands: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.12.3 Netherlands: Europe Clinical Trials Market Share - by Phase Type
      • 9.1.2.13 Rest of Europe: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.2.13.1 Rest of Europe: Europe Clinical Trials Market Share - by Study Design
        • 9.1.2.13.2 Rest of Europe: Europe Clinical Trials Market Share - by Indications
        • 9.1.2.13.3 Rest of Europe: Europe Clinical Trials Market Share - by Phase Type

10. Competitive Landscape

  • 10.1 Heat Map Analysis by Key Players
  • 10.2 Company Positioning and Concentration

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Clinical Trials Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 QVIA Holdings Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Parexel International Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 IXICO Plc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Charles River Laboratories International Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 ICON Plc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 WuXi AppTec Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 SGS SA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Syneos Health Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 SIRO Clinpharm Pvt Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Thermo Fisher Scientific Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Laboratory Corp of America Holdings
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 CliniRx Research Private Limited
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Caidya
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Oracle Corp
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Medpace Holdings Inc
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 List of Abbreviations

List Of Tables

  • Table 1. Europe Clinical Trials Market Segmentation
  • Table 2. Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Study Design
  • Table 4. Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Indications
  • Table 5. Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Phase Type
  • Table 6. Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. United Kingdom: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 8. United Kingdom: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 9. United Kingdom: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 10. Germany: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 11. Germany: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 12. Germany: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 13. France: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 14. France: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 15. France: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 16. Spain: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 17. Spain: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 18. Spain: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 19. Italy: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 20. Italy: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 21. Italy: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 22. Poland: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 23. Poland: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 24. Poland: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 25. Switzerland: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 26. Switzerland: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 27. Switzerland: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 28. Sweden: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 29. Sweden: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 30. Sweden: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 31. Denmark: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 32. Denmark: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 33. Denmark: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 34. Belgium: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 35. Belgium: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 36. Belgium: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 37. Netherlands: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 38. Netherlands: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 39. Netherlands: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 40. Rest of Europe: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Study Design
  • Table 41. Rest of Europe: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Indications
  • Table 42. Rest of Europe: Europe Clinical Trials Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Phase Type
  • Table 43. Recent Organic Growth Strategies in Clinical Trials Market
  • Table 44. Recent Inorganic Growth Strategies in the Clinical Trials Market
  • Table 45. List of Abbreviations

List Of Figures

  • Figure 1. Europe Clinical Trials Market Segmentation - Country
  • Figure 2. Europe Clinical Trials Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Clinical Trials Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Clinical Trials Market Share (%) - by Study Design (2023 and 2031)
  • Figure 6. Interventional Trials: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Expanded Access Trials: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Europe Clinical Trials Market Share (%) - by Indications (2023 and 2031)
  • Figure 9. Autoimmune/Inflammation: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Pain Management: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Oncology: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Neurological Disorders: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Diabetes: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Obesity: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Metabolic Disorders: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Cardiovascular: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Others: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Europe Clinical Trials Market Share (%) - by Phase Type (2023 and 2031)
  • Figure 19. Phase I: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Phase II: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Phase III: Europe Clinical Trials Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Europe Clinical Trials Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 23. United Kingdom: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Germany: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. France: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Spain: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Italy: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 28. Poland: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 29. Switzerland: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 30. Sweden: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 31. Denmark: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 32. Belgium: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 33. Netherlands: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 34. Rest of Europe: Europe Clinical Trials Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 35. Heat Map Analysis by Key Players
  • Figure 36. Company Positioning and Concentration
  • Figure 37. Growth Strategies in Clinical Trials Market